Navigation Links
Alternatives Available Nationwide to Addictive Benzodiazepines for Anxiety
Date:1/2/2017

BIRMINGHAM, Ala., Jan. 2, 2017 /PRNewswire/ -- The pharmaceutical research company TPD LLC (Trends in Pharma Development) announced that the PanX® new class of medicines intended for the treatment of anxiety are now available nationwide as prescription compounded drugs.

Two US patents 9,446,030 and 9,517,231 were recently issued to the company in September and December, respectively.  The patents broadly cover dual drug combinations of historically-safe active ingredients that are being re-purposed for the treatment of anxiety disorders, such as social anxiety disorder, panic, and PTSD. The combinations were designed to suppress the multiple symptoms of acute anxiety.

The PanX® drugs are intended as "as needed" alternatives to benzodiazepines (e.g., Xanax® or Valium®) that are addictive, have the potential for abuse, and are Controlled Substances.  However, the active ingredients in the PanX® brand, beta blockers and antiemetic motion sickness agents, have no history of addiction or abuse in five decades of prescription or over-the-counter use.  The company's goal for the patented new class of medicines is to provide effective, fast-acting, yet safer alternatives to benzodiazepines.

According to a leading authority on anxiety therapies, Professor Charles B. Nemeroff, MD PhD, Chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami, "A number of patients with prominent anxiety symptoms do not respond or cannot tolerate currently available treatments. This novel approach combining two medications with distinct mechanisms of action has the potential to fill an important niche in the management of such patients."

TPD has contracted with Pine Pharmaceuticals and Pine Pharmacy of New York, and Custom Meds of Florida to produce the products as prescription compounded drugs.  The combination drug products are available in 49 states as patient-specific prescriptions by mail order and/or as "office use" medications administered by physicians, for instance in medical procedures when patients are anxious or fearful.  For additional information see www.PanX.us.

TPD is also pursuing the clinical development of selected PanX® drugs to seek product approval by the US Food and Drug Administration (FDA).

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alternatives-available-nationwide-to-addictive-benzodiazepines-for-anxiety-300384404.html


'/>"/>
SOURCE TPD LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. RI Physical Therapist Discusses Alternatives to Rising Opioid Use
2. EpiBiome Secures $6 Million Series A Financing to Develop Alternatives to Small-Molecule Antibiotics for Agriculture
3. KaloBios to Reduce Workforce, Explore Strategic Alternatives
4. The Manufacturer of the SynCardia Total Artificial Heart has Hired Investment Bank Canaccord Genuity, Inc. to Advise the BOD on Strategic Alternatives to Maximize Stakeholder Equity
5. Unilife Announces Review of Strategic Alternatives
6. As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation
7. Pessaries and Other Vaginal Mesh Alternatives Discussed by Life Care Solutions Group
8. BioNet Received Thai FDA Approval of the Worlds Only Available Recombinant Monovalent Acellular Pertussis (aP) Vaccine
9. Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option
10. Zymo Research Announces Nucleic Acid Purification Kits Now Available on Amazon.com
11. In-home PFT Testing Is Now Available to Patients with ndd Medicals Mobile EasyOne Pro
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... Mich. , July 13, 2017  Centurion Medical Products, a ... its DisImpactor ® fecal impaction removal device for hospice patient ... ... Patient pain management and ... for Hospice can help alleviate patient pain while preventing unneeded emergency ...
(Date:7/11/2017)... IRVINE, Calif. , July 11, 2017 Zymo Research Corp., ... new service that can quantify biological aging in a precise manner using ... Dr. Steve Horvath , a professor of human genetics and biostatistics ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... loci. ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare Partners is ... continued efforts to provide innovative offerings to their healthcare partners. These solutions will ... dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding Talent Management ...
(Date:7/26/2017)... ... ... may be hard to imagine that the basic necessities that developed countries take for ... developed countries consider rare or eradicated, like measles, are still a rite of passage ... segment of "Success Files", actor Rob Lowe will introduce a new segment that will ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... will host its 2017 Process Validation and Process Validation Statistics Conferences in ... to process validation lifecycle challenges faced by process validation professionals and statisticians ...
(Date:7/26/2017)... Newport Beach, CA 92660 (PRWEB) , ... ... ... of Data Loss Prevention for on-premises, off and in the cloud ; today ... intelligent detection and scientific algorithms within a simple to use control console for ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with Six ... schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing patients ... will bring more Six Month Smiles patients to their providers.” , Each month, over ...
Breaking Medicine News(10 mins):